FindTrial
Sign In

Use of intravenous aminophylline in acute severe asthma in children aged 2 to 14 years and mean time taken to reduce the asthma severity score .

Intravenous aminophylline as a rescue therapy in pediatric status asthmaticus- observational study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072993
Enrollment
56
Registered
2024-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: nil: nil Intervention2: nil: nil Intervention3: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Rini Salim
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Child with status astmatic admitted to PICU using intravenous aminophylline

Exclusion criteria

Exclusion criteria: Children allergic to aminophylline. Children who have received theophylline derivative in last 2 weeks. Pre existing cardiology, neurology disease Non consenting participants.

Design outcomes

Primary

MeasureTime frame
use of intravenous aminophylline as a rescue therapy in pediatric status asthmatics and how it help in reducing clinical severity score.Timepoint: every 4th hour—

Secondary

MeasureTime frame
Side effects of aminophylline , number of days in ICU and hospital. proportion of children with non invasive ventilationTimepoint: 1 year 6 months—

Countries

India

Contacts

Public ContactDr Prameela Joji

KIMSHEALTH, Trivandrum

drprameelajoji@yahoo.co.in9847324933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026